We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.16%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$159B
AUM Growth
+$9.87B
Cap. Flow
+$6.55B
Cap. Flow %
4.11%
Top 10 Hldgs %
17.08%
Holding
8,498
New
792
Increased
3,382
Reduced
3,111
Closed
693

Sector Composition

Rank Sector Weight
1 Healthcare 6.74%
2 Financials 6.2%
3 Technology 5.53%
4 Industrials 5.36%
5 Energy 4.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HBIO icon
6626
Harvard Bioscience
HBIO
$27.5M
$12K ﹤0.01%
412
+227
+123% +$7.22K
HFWA icon
6627
Heritage Financial
HFWA
$1.22B
$12K ﹤0.01%
700
-76
-10% -$1.34K
HSCZ icon
6628
iShares Currency Hedged MSCI EAFE Small-Cap ETF
HSCZ
$239M
$12K ﹤0.01%
+518
New +$12.2K
JSMD icon
6629
Janus Henderson Small/Mid Cap Growth Alpha ETF
JSMD
$1.05B
$12K ﹤0.01%
+426
New +$11.8K
KPTI icon
6630
Karyopharm Therapeutics
KPTI
$43.5M
$12K ﹤0.01%
120
-4
-3% -$520
KVHI icon
6631
KVH Industries
KVHI
$181M
$12K ﹤0.01%
1,555
+474
+44% +$4.12K
LODE icon
6632
Comstock
LODE
$208M
$12K ﹤0.01%
133
+115
+639% +$11.2K
MTR
6633
Mesa Royalty Trust
MTR
$5.4M
$12K ﹤0.01%
1,143
+643
+129% +$5.84K
NHC icon
6634
National Healthcare
NHC
$3.53B
$12K ﹤0.01%
183
-204,076
-100% -$13M
NL icon
6635
NLI Holdings
NL
$281M
$12K ﹤0.01%
+4,583
New +$13.1K
PRO
6636
DELISTED
PROS Holdings
PRO
$12K ﹤0.01%
700
UAE icon
6637
iShares MSCI UAE ETF
UAE
$308M
$12K ﹤0.01%
736
-735
-50% -$12.3K
TVRD
6638
Tvardi Therapeutics
TVRD
$19.7M
$12K ﹤0.01%
69
+55
+393% +$12K
DLA
6639
DELISTED
Delta Apparel Inc.
DLA
$12K ﹤0.01%
550
-6,710
-92% -$139K
SCTL
6640
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$12K ﹤0.01%
1,745
-2,219
-56% -$14.8K
NM.PRG
6641
DELISTED
NAVIOS MARITIME HOLDINGS INC. American Depositary Shares, each representing 1/100th of a 8.75% Series G Cummulative Redeemable Perpetual Preferred Stock, $0.0001 par value
NM.PRG
$12K ﹤0.01%
2,865
-3,710
-56% -$16K
KFYP
6642
DELISTED
KraneShares CICC China Leaders 100 Index ETF
KFYP
$12K ﹤0.01%
444
-1,680
-79% -$45.6K
LHCG
6643
DELISTED
LHC Group LLC
LHCG
$12K ﹤0.01%
287
-37
-11% -$1.51K
CALA
6644
DELISTED
Calithera Biosciences, Inc
CALA
$12K ﹤0.01%
+160
New +$16K
ZJPN
6645
DELISTED
SPDR Solactive Japan ETF
ZJPN
$12K ﹤0.01%
181
-462
-72% -$29.4K
PRGX
6646
DELISTED
PRGX Global, Inc.
PRGX
$12K ﹤0.01%
2,384
-345
-13% -$1.7K
TSLF
6647
DELISTED
THL CREDIT SENIOR LOAN FUND
TSLF
$12K ﹤0.01%
+727
New +$11.6K
ARQL
6648
DELISTED
Arqule Inc
ARQL
$12K ﹤0.01%
6,661
-64,869
-91% -$110K
DEST
6649
DELISTED
Destination Maternity Corporation
DEST
$12K ﹤0.01%
1,998
+1,663
+496% +$10.9K
DFBG
6650
DELISTED
Differential Brands Group Inc
DFBG
$12K ﹤0.01%
+4,225
New +$17.8K

Similar funds

UBS Group's Q2 2016 Portfolio in Review

As of Q2 2016, UBS Group held 8,498 positions worth $159B, up 6.6% from $149B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

UBS Group deployed $6.55B of net new capital in Q2 2016, opening 792 new positions and adding to 3,382 existing holdings. Its largest new stake was ProShares Ultra VIX Short-Term Futures ETF: 2 shares worth $29M.

By sector, the portfolio is most concentrated in Healthcare at 6.7% of assets, up from 6.7% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $645M trimmed.

  • UBS Group's largest Q2 2016 buy was ProShares Ultra VIX Short-Term Futures ETF: 2 shares worth $29M.
  • UBS Group added most to Chubb in Q2 2016, an estimated $275M increase.
  • UBS Group's biggest Q2 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $645M.
  • UBS Group fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $406M.
  • UBS Group's ten largest holdings make up 17% of its $159B portfolio in Q2 2016.
  • UBS Group opened 792 new positions and closed 693 in Q2 2016.
  • UBS Group's portfolio value rose 6.6% quarter-over-quarter to $159B.

Based on UBS Group's 13F filing for Q2 2016, filed 12 Aug 2016.